524 related articles for article (PubMed ID: 17909104)
1. CC chemokine ligand-5 (CCL5/RANTES) and CC chemokine ligand-18 (CCL18/PARC) are specific markers of refractory unstable angina pectoris and are transiently raised during severe ischemic symptoms.
Kraaijeveld AO; de Jager SC; de Jager WJ; Prakken BJ; McColl SR; Haspels I; Putter H; van Berkel TJ; Nagelkerken L; Jukema JW; Biessen EA
Circulation; 2007 Oct; 116(17):1931-41. PubMed ID: 17909104
[TBL] [Abstract][Full Text] [Related]
2. Cardiovascular determinants and prognostic significance of CC Chemokine Ligand-18 (CCL18/PARC) in patients with stable coronary artery disease.
De Sutter J; Struyf S; Van de Veire NR; Philippé J; De Buyzere M; Van Damme J
J Mol Cell Cardiol; 2010 Nov; 49(5):894-6. PubMed ID: 20674579
[TBL] [Abstract][Full Text] [Related]
3. CCL3 (MIP-1 alpha) levels are elevated during acute coronary syndromes and show strong prognostic power for future ischemic events.
de Jager SC; Kraaijeveld AO; Grauss RW; de Jager W; Liem SS; van der Hoeven BL; Prakken BJ; Putter H; van Berkel TJ; Atsma DE; Schalij MJ; Jukema JW; Biessen EA
J Mol Cell Cardiol; 2008 Sep; 45(3):446-52. PubMed ID: 18619972
[TBL] [Abstract][Full Text] [Related]
4. CC-chemokine ligand 18/pulmonary activation-regulated chemokine expression in the CNS with special reference to traumatic brain injuries and neoplastic disorders.
Chang CY; Lee YH; Leu SJ; Wang CY; Wei CP; Hung KS; Pai MH; Tsai MD; Wu CH
Neuroscience; 2010 Feb; 165(4):1233-43. PubMed ID: 19958819
[TBL] [Abstract][Full Text] [Related]
5. Y-box binding protein-1 controls CC chemokine ligand-5 (CCL5) expression in smooth muscle cells and contributes to neointima formation in atherosclerosis-prone mice.
Krohn R; Raffetseder U; Bot I; Zernecke A; Shagdarsuren E; Liehn EA; van Santbrink PJ; Nelson PJ; Biessen EA; Mertens PR; Weber C
Circulation; 2007 Oct; 116(16):1812-20. PubMed ID: 17893273
[TBL] [Abstract][Full Text] [Related]
6. Increased expression of CC chemokine ligand 18 in extrinsic atopic dermatitis patients.
Park CO; Lee HJ; Lee JH; Wu WH; Chang NS; Hua L; Lee MG; Lee KH
Exp Dermatol; 2008 Jan; 17(1):24-9. PubMed ID: 17979978
[TBL] [Abstract][Full Text] [Related]
7. Serum levels of the Th1 promoter IL-12 and the Th2 chemokine TARC are elevated in erythema multiforme and Stevens-Johnson syndrome/toxic epidermal necrolysis and correlate with soluble Fas ligand expression. An immunoenzymatic study from the Italian Group of Immunopathology.
Quaglino P; Caproni M; Antiga E; Del Bianco E; Osella-Abate S; Savoia P; Frezzolini A; Schena D; Marzano A; Volpi W; De Simone C; Parodi A; Fabbri P; Bernengo MG;
Dermatology; 2007; 214(4):296-304. PubMed ID: 17460400
[TBL] [Abstract][Full Text] [Related]
8. [Correlation of chemokines and chemokine receptors with clinical features in newly diagnosed systemic lupus erythematosus].
Tao JH; Li XP; Li XM; Kan M; Zhai ZM; Wang W
Zhonghua Yi Xue Za Zhi; 2006 Nov; 86(43):3051-4. PubMed ID: 17288835
[TBL] [Abstract][Full Text] [Related]
9. High CCL18/PARC expression in articular cartilage and synovial tissue of patients with rheumatoid arthritis.
Momohara S; Okamoto H; Iwamoto T; Mizumura T; Ikari K; Kawaguchi Y; Takeuchi M; Kamatani N; Tomatsu T
J Rheumatol; 2007 Feb; 34(2):266-71. PubMed ID: 17304652
[TBL] [Abstract][Full Text] [Related]
10. Elevated plasma chemokine CCL18/PARC in beta-thalassemia.
Dimitriou E; Verhoek M; Altun S; Karabatsos F; Moraitou M; Youssef J; Boot R; Sarafidou J; Karagiorga M; Aerts H; Michelakakis H
Blood Cells Mol Dis; 2005; 35(3):328-31. PubMed ID: 16137900
[TBL] [Abstract][Full Text] [Related]
11. Novel monoclonal antibodies detect elevated levels of the chemokine CCL18/DC-CK1 in serum and body fluids in pathological conditions.
van der Voort R; Kramer M; Lindhout E; Torensma R; Eleveld D; van Lieshout AW; Looman M; Ruers T; Radstake TR; Figdor CG; Adema GJ
J Leukoc Biol; 2005 May; 77(5):739-47. PubMed ID: 15713699
[TBL] [Abstract][Full Text] [Related]
12. Differential expression of chemokines and chemokine receptors in inflammatory periapical diseases.
Silva TA; Garlet GP; Lara VS; Martins W; Silva JS; Cunha FQ
Oral Microbiol Immunol; 2005 Oct; 20(5):310-6. PubMed ID: 16101967
[TBL] [Abstract][Full Text] [Related]
13. Chemokine CCL5/RANTES inhibition reduces myocardial reperfusion injury in atherosclerotic mice.
Braunersreuther V; Pellieux C; Pelli G; Burger F; Steffens S; Montessuit C; Weber C; Proudfoot A; Mach F; Arnaud C
J Mol Cell Cardiol; 2010 Apr; 48(4):789-98. PubMed ID: 19665464
[TBL] [Abstract][Full Text] [Related]
14. Chemokines CCL3/MIP1α, CCL5/RANTES and CCL18/PARC are independent risk predictors of short-term mortality in patients with acute coronary syndromes.
de Jager SC; Bongaerts BW; Weber M; Kraaijeveld AO; Rousch M; Dimmeler S; van Dieijen-Visser MP; Cleutjens KB; Nelemans PJ; van Berkel TJ; Biessen EA
PLoS One; 2012; 7(9):e45804. PubMed ID: 23029252
[TBL] [Abstract][Full Text] [Related]
15. Platelet-derived chemokine RANTES may be a sign of restenosis after percutaneous coronary intervention in patients with stable angina pectoris.
Inami N; Nomura S; Manabe K; Kimura Y; Iwasaka T
Platelets; 2006 Dec; 17(8):565-70. PubMed ID: 17127484
[TBL] [Abstract][Full Text] [Related]
16. Elevation of platelet activation markers and chemokines during peripheral blood stem cell harvest with G-CSF.
Nomura S; Inami N; Kanazawa S; Iwasaka T; Fukuhara S
Stem Cells; 2004; 22(5):696-703. PubMed ID: 15342934
[TBL] [Abstract][Full Text] [Related]
17. The role of chemokines in exercise-induced bronchoconstriction in asthma.
Tahan F; Karaaslan C; Aslan A; Kiper N; Kalayci O
Ann Allergy Asthma Immunol; 2006 Jun; 96(6):819-25. PubMed ID: 16802769
[TBL] [Abstract][Full Text] [Related]
18. Differential expression of chemokines, risk of stable coronary heart disease, and correlation with established cardiovascular risk markers.
Rothenbacher D; Müller-Scholze S; Herder C; Koenig W; Kolb H
Arterioscler Thromb Vasc Biol; 2006 Jan; 26(1):194-9. PubMed ID: 16239601
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-7-mediated inflammation in unstable angina: possible role of chemokines and platelets.
Damås JK; Waehre T; Yndestad A; Otterdal K; Hognestad A; Solum NO; Gullestad L; Frøland SS; Aukrust P
Circulation; 2003 Jun; 107(21):2670-6. PubMed ID: 12742982
[TBL] [Abstract][Full Text] [Related]
20. The urokinase-type plasminogen activator/its soluble receptor system is independently related to carotid atherosclerosis and associated with CC-chemokines in uraemic patients.
Pawlak K; Mysliwiec M; Pawlak D
Thromb Res; 2008; 122(3):328-35. PubMed ID: 18048089
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
